1-20 of 36631
Sort by
Journal Article
Se-Eun Kim and others
EP Europace, Volume 27, Issue 4, April 2025, euaf043, https://doi.org/10.1093/europace/euaf043
Published: 10 April 2025
Image
Published: 10 April 2025
Graphical Abstract Graphical Abstract Cardiac magnetic resonance tissue parameters as predictors for CRT response in NICM. Among 101 patients who underwent CMR before CRT implantation, 71.3% were CRT responders, who had lower LGE burden, baseline T1, T2, and ECV values. In contrast, 28.7% were CRT non-responders,
Image
Published: 10 April 2025
Figure 2 Clinical outcomes according to ECV and LGE burden. ECV, extracellular volume; LGE, late gadolinium enhancement.
Image
Published: 10 April 2025
Figure 1 Receiver operating characteristic curves displaying CMR parameters as predictors of CRT response. AUC, area under the ROC curve; CI, confidence interval; CRT, cardiac resynchronization therapy; ECV, extracellular volume; LGE, late gadolinium enhancement; ROC, receiver operating characteristics.
Image
Published: 08 April 2025
Graphical Abstract Graphical Abstract
Image
Published: 08 April 2025
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT
Claudia A Manetti and others
Published: 08 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Xue-Si Wang and others
Published: 08 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Han Li and others
Published: 05 April 2025
Image
Published: 05 April 2025
Graphical abstract Graphical abstract
Image
Published: 05 April 2025
Graphical abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT
Zhen Cao and others
Published: 05 April 2025
Journal Article
EP Europace, Volume 27, Issue 4, April 2025, euaf078, https://doi.org/10.1093/europace/euaf078
Published: 04 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Alexandre Salaun and others
Published: 02 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Elijah R Behr and others
Published: 01 April 2025
Image
Published: 01 April 2025
Graphical Abstract Graphical Abstract
Journal Article
Marco Vitolo and others
EP Europace, Volume 27, Issue 4, April 2025, euaf063, https://doi.org/10.1093/europace/euaf063
Published: 01 April 2025
Image
Published: 01 April 2025
Figure 1 Flecainide, synthetized in 1972 as a result of studies on analogues of procainamide, is used for conversion of atrial fibrillation, with various routes of administration, including the classical intravenous and oral administrations, as well as the novel inhaled formulation. The standard doses, times
Journal Article
ACCEPTED MANUSCRIPT
Roland R Tilz and others
Published: 31 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Jean-Claude Deharo and others
Published: 31 March 2025